Sherbrooke Park Advisers LLC Takes Position in Tenet Healthcare Co. (NYSE:THC)

Sherbrooke Park Advisers LLC acquired a new stake in Tenet Healthcare Co. (NYSE:THCFree Report) in the 4th quarter, Holdings Channel.com reports. The institutional investor acquired 7,708 shares of the company’s stock, valued at approximately $973,000.

Other large investors have also modified their holdings of the company. Norges Bank acquired a new stake in shares of Tenet Healthcare during the fourth quarter worth $190,819,000. Wealthfront Advisers LLC acquired a new stake in shares of Tenet Healthcare during the fourth quarter worth $69,059,000. Raymond James Financial Inc. acquired a new stake in shares of Tenet Healthcare during the fourth quarter worth $49,001,000. Renaissance Technologies LLC boosted its position in shares of Tenet Healthcare by 579.2% during the 4th quarter. Renaissance Technologies LLC now owns 438,563 shares of the company’s stock worth $55,360,000 after purchasing an additional 373,988 shares in the last quarter. Finally, Bridgewater Associates LP grew its stake in shares of Tenet Healthcare by 225.4% during the 4th quarter. Bridgewater Associates LP now owns 407,194 shares of the company’s stock worth $51,400,000 after purchasing an additional 282,071 shares during the period. 95.44% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of equities analysts have recently weighed in on the stock. Robert W. Baird reaffirmed a “neutral” rating and set a $137.00 price target (down from $153.00) on shares of Tenet Healthcare in a research note on Tuesday, April 15th. Royal Bank of Canada upped their price target on shares of Tenet Healthcare from $183.00 to $189.00 and gave the stock an “outperform” rating in a research note on Wednesday, April 30th. TD Cowen started coverage on shares of Tenet Healthcare in a research note on Wednesday, February 26th. They set a “buy” rating and a $175.00 price target on the stock. UBS Group raised their price target on Tenet Healthcare from $217.00 to $230.00 and gave the company a “buy” rating in a research report on Wednesday, April 30th. Finally, Baird R W cut Tenet Healthcare from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, April 15th. Four research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, Tenet Healthcare has an average rating of “Moderate Buy” and a consensus target price of $174.94.

Read Our Latest Research Report on Tenet Healthcare

Insider Activity

In other news, Director J Robert Kerrey sold 5,001 shares of Tenet Healthcare stock in a transaction dated Friday, May 9th. The stock was sold at an average price of $148.50, for a total value of $742,648.50. Following the transaction, the director now directly owns 22,377 shares of the company’s stock, valued at $3,322,984.50. The trade was a 18.27% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Corporate insiders own 0.81% of the company’s stock.

Tenet Healthcare Stock Up 2.8%

THC opened at $163.96 on Friday. The company has a debt-to-equity ratio of 2.25, a current ratio of 1.78 and a quick ratio of 1.70. The stock has a market capitalization of $15.23 billion, a price-to-earnings ratio of 5.09, a price-to-earnings-growth ratio of 1.02 and a beta of 1.63. The business has a 50-day moving average of $131.99 and a two-hundred day moving average of $136.42. Tenet Healthcare Co. has a 12 month low of $109.82 and a 12 month high of $171.20.

Tenet Healthcare (NYSE:THCGet Free Report) last posted its quarterly earnings results on Tuesday, April 29th. The company reported $4.36 EPS for the quarter, beating the consensus estimate of $3.11 by $1.25. The company had revenue of $5.22 billion during the quarter, compared to analysts’ expectations of $5.15 billion. Tenet Healthcare had a return on equity of 21.88% and a net margin of 15.48%. The firm’s revenue was down 2.5% on a year-over-year basis. During the same quarter in the previous year, the business earned $3.22 EPS. On average, research analysts expect that Tenet Healthcare Co. will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

(Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Featured Articles

Want to see what other hedge funds are holding THC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Tenet Healthcare Co. (NYSE:THCFree Report).

Institutional Ownership by Quarter for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.